Key result
Comprehensive CMD testing may improve symptoms and QoL by guiding targeted medical therapy.
Why the study?
Coronary microvascular disease causes myocardial ischemia in diverse clinical scenarios, but additional education and provider awareness are needed to improve patient-centered outcomes in ischemic heart disease.
Comprehensive invasive testing for coronary microvascular disease can guide targeted therapy and improve patient outcomes in various clinical scenarios.
Answers are grounded in this paper and cite their sources.
May support CMD testing to guide therapy in select patients; hypothesis-generating and requires RCTs before practice change.
Coronary microvascular disease (CMD) causes myocardial ischemia in a variety of clinical scenarios. Clinical practice guidelines support routine testing for CMD in patients with ischemia with nonobstructive coronary artery disease. Invasive testing to identify CMD requires Doppler or thermodilution measures of flow to determine the coronary flow reserve and measures of microvascular resistance. Acetylcholine coronary reactivity testing identifies concomitant endothelial dysfunction, microvascular spasm, or epicardial coronary spasm. Comprehensive testing may improve symptoms, quality of life, and patient satisfaction by establishing a diagnosis and guiding-targeted medical therapy and lifestyle measures. Beyond ischemia with nonobstructive coronary artery disease, testing for CMD may play a role in patients with acute myocardial infarction, angina following coronary revascularization, heart failure with preserved ejection fraction, Takotsubo syndrome, and after heart transplantation. Additional education and provider awareness of CMD and its role in cardiovascular disease is needed to improve patient-centered outcomes of ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Smilowitz et al. (2023) conducted a review in Coronary microvascular disease. Testing for coronary microvascular disease was evaluated. Comprehensive testing for coronary microvascular disease may improve symptoms and quality of life by establishing a diagnosis and guiding targeted medical therapy across various clinical scenarios.
Synapse has enriched 10 related papers. Consider them for comparative context: